
bluebird bio Inc
NASDAQ:BLUE

Intrinsic Value
The intrinsic value of one
BLUE
stock under the Base Case scenario is
337.52
USD.
Compared to the current market price of 4.97 USD,
bluebird bio Inc
is
Undervalued by 99%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
bluebird bio Inc
Balance Sheet Decomposition
bluebird bio Inc
Current Assets | 154.7m |
Cash & Short-Term Investments | 62.3m |
Receivables | 3.1m |
Other Current Assets | 89.3m |
Non-Current Assets | 305.6m |
PP&E | 237.7m |
Intangibles | 15.2m |
Other Non-Current Assets | 52.6m |
Free Cash Flow Analysis
bluebird bio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
bluebird bio Inc
Revenue
|
83.8m
USD
|
Cost of Revenue
|
-89.4m
USD
|
Gross Profit
|
-5.6m
USD
|
Operating Expenses
|
-262.1m
USD
|
Operating Income
|
-267.7m
USD
|
Other Expenses
|
27m
USD
|
Net Income
|
-240.7m
USD
|
BLUE Profitability Score
Profitability Due Diligence
bluebird bio Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
bluebird bio Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
BLUE Solvency Score
Solvency Due Diligence
bluebird bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
bluebird bio Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BLUE Price Targets Summary
bluebird bio Inc
According to Wall Street analysts, the average 1-year price target for
BLUE
is 7.34 USD
with a low forecast of 5.05 USD and a high forecast of 10.5 USD.
Dividends
Current shareholder yield for BLUE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?